Simon Bolam

Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes

Simon Bolam, Jenny Orchard, David Oscier · British Journal of Haematology · 1997 · 54 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real‐world analysis of outcomes in 211 patients

Rory McCulloch, David Lewis, Nicola Crosbie et al. · British Journal of Haematology · 2021 · 53 citations · Full text

Medicine, Hematology, Oncology +17

Venetoclax–based low intensity therapy in molecular failure of <i>NPM1</i>-mutated AML

Carlos Jiménez‐Chillón, Jad Othman, David Taussig et al. · Blood Advances · 2023 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

The addition of rituximab to fludarabine and cyclophosphamide chemotherapy results in a significant improvement in overall survival in patients with newly diagnosed mantle cell lymphoma: results of a randomized UK National Cancer Research Institute trial

Simon Rule, Paul D. Smith, Peter Johnson et al. · Haematologica · 2015 · 26 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

The Addition of Rituximab to Fludarabine and Cyclophosphamide (FC) Improves Overall Survival in Newly Diagnosed Mantle Cell Lymphoma (MCL): Results of the Randomised UK National Cancer Research Institute (NCRI) Trial

Simon Rule, Paul Smith, Peter Johnson et al. · Blood · 2011 · 19 citations

Medicine, Oncology, Pharmacotherapy +13